Skip to main content
Etropal AD logo

Etropal AD — Investor Relations & Filings

Ticker · ETR ISIN · BG1100001038 LEI · 747800F04CMOK74FIJ68 BSOBGN Manufacturing
Open in API
Filings indexed 84 across all filing types
Latest filing 2026-03-01 Annual Report
Country BG Bulgaria
Listing BSOBGN ETR

About Etropal AD

https://www.etropal.eu/

Etropal AD is a manufacturer of disposable medical devices, primarily focused on providing life-sustaining care for patients with end-stage renal disease. The company's core activities include the research, development, and production of a comprehensive range of hemodialysis consumables, such as capillary dialyzers. In addition to its focus on dialysis solutions, the company is also active in the field of orthopedics and traumatology. This secondary business line involves the manufacturing of endoprostheses, implants, specialized bioceramic materials, and surgical instruments. With over thirty years of experience, Etropal AD offers a broad spectrum of products that meet high standards of safety and quality.

Recent filings

Filing Released Lang Actions
678858-годишни и шестмесечни справки на консолидирана основа.xlsx
Annual Report Classification · 95% confidence The document contains detailed consolidated financial data including a balance sheet with assets, liabilities, and equity for the fiscal year starting 2025-01-01 and ending 2025-12-31. It is prepared by a chief accountant and includes comprehensive financial figures for current and previous periods. The length of the document is substantial (15,000 characters), indicating it is not a mere announcement or certification. The presence of full financial statements and detailed accounting data for a full fiscal year strongly indicates this is an Annual Report (10-K equivalent). The document is not a short announcement, certification, or partial report, and it contains substantive financial data and analysis for the full year. Therefore, the correct classification is Annual Report (10-K).
2026-03-01 Norwegian Nynorsk
Декларация по чл.100.pdf
Regulatory Filings Classification · 95% confidence The document is a formal declaration signed by the executive member and the financial statement compiler of Etropal AD, pursuant to Article 100o of the Public Offering of Securities Act (ZPPTSK). It confirms the accuracy of the interim consolidated financial report and the interim management report for the fourth quarter of 2025. Since this is a regulatory declaration accompanying financial reports rather than the financial report itself, and it does not fit into specific categories like 'RPA' (which is for announcements of publication) or 'IR' (which is the report itself), it is best classified as a general regulatory filing.
2026-03-01 Bulgarian
675083-ETROPAL_Ind. GFO 31.12.2025_po MSS.pdf
Audit Report / Information Classification · 98% confidence The document contains a comprehensive set of financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Cash Flows, and Statement of Changes in Equity for the fiscal year ending December 31, 2025. It includes comparative data for 2024 and is signed off by the Board of Directors. Given the depth and completeness of the financial data provided, it qualifies as an Annual Report (10-K). FY 2025
2026-01-28 Bulgarian
675085-ETR_Q4'2025.xlsx
Annual Report Classification · 95% confidence The document contains detailed financial data including a balance sheet (accounting balance), with figures for assets, liabilities, equity, and other financial statement line items. It covers a full fiscal year period from 2025-01-01 to 2025-12-31 and is dated 2026-01-20, indicating it is a comprehensive annual financial report. The presence of detailed financial statement data and the length of the document (15,000 characters) confirm it is not a mere announcement or certification. The document is in Bulgarian and references regulatory requirements for public companies, consistent with an Annual Report. Therefore, the document is best classified as an Annual Report (10-K).
2026-01-28 Norwegian Nynorsk
675089-Management report Q4_2025_ind.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Interim Activity Report' (Междинен доклад за дейността) for the fourth quarter of 2025 for 'Etropal' AD. It contains detailed financial results, balance sheet data, analysis of business operations, and risk factors. It is a comprehensive financial report for a period shorter than a full fiscal year, containing actual financial statements and analysis, thus fitting the definition of an Interim/Quarterly Report. Q4 2025
2026-01-28 Bulgarian
675084-BEL.ETROPAL_Ind. _GFO_31.12.2025po MSS.pdf
Audit Report / Information Classification · 98% confidence The document is titled 'Notes to the Annual Non-Consolidated Financial Statement' for the period 01.01.2025 to 31.12.2025. It contains detailed accounting policies, management information, and financial reporting disclosures. While it is part of the annual reporting package, it is specifically the 'Notes' section of the Annual Report. In the context of financial filings, this constitutes the core content of an Annual Report (10-K equivalent for the jurisdiction). FY 2025
2026-01-28 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.